Social Links

Follow on Facebook Follow on TwitterFollow EiR on PinterestFollow EiR on Instagram

Xpert Access

×

Login To Get Involved!


Forgot your username?


Forgot your password?

×

Join Us At EiR Now!

DNRS Roof Banner

 

DNRS Interactive DVD Series & Seminars

Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis

 

 

 

Clin Exp Pharmacol Physiol. 2009 Apr 27. [Epub ahead of print]

 

Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.

 

Wang Y, Jia XM, Jia JH, Li MB, Cao YY, Gao PH, Liao WQ, Cao YB, Jiang YY. School of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.

 

 

1. The aim of the present study was to investigate the effects of ascorbic acid (AA) on the antifungal activity of fluconazole (FCZ) in a systemic murine candidiasis model and in vitro.

 

2. Murine model was established by infusion of Candida albicans via the tail vein. FCZ (0.5 mg/kg) was given to animals in the corresponding groups intraperitoneally; AA was given to animals intragastrically or intraperitoneally at 50 mg/kg or 500 mg/kg. The survival rate, kidney fungal burden and renal pathological changes were evaluated. The in vitro effects of AA (5, 1, and 0.2 mM) on growth of various Candida strains in the presence of FCZ were investigated. The in vitro effects of two anti-oxidants, N-acetylcysteine (5, 1 and 0.2 mM) and reduced glutathione (5, 1 and 0.2 mM), on FCZ activity were determined to investigate the mechanism of AA's action.

 

3. We found that intragastric administration of AA (50 or 500 mg/kg) significantly decreased the antifungal effect of 0.5 mg/kg FCZ. Although intraperitoneal administration of AA (50 or 500 mg/kg) had no significant effect on the survival of mice, it inhibited the activity of FCZ dose-dependently; the inhibition was significant when AA was at 500mg/kg. In vitro, AA decreased the activity of FCZ against various Candida strains, and N-acetylcysteine and reduced glutathione decreased the activity of FCZ dose-dependently.

 

4. Our results demonstrate that AA can inhibit the antifungal activity of FCZ, suggesting that the two should not be used together clinically for treatment of candidiasis.

 

PMID: 19413603 [PubMed - as supplied by publisher]

 


 

 

Related Articles:

 

  • No comments found

Leave your comments

Post comment as a guest

0 Character restriction
Your text should be more than 25 characters
Your comments are subjected to administrator's moderation.
terms and condition.

Adsense Responsive BottomBanner